IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas
Science Advances · 29.08.2025 · 11 (35)
DOI: 10.1126/sciadv.adp9391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 29.08.2025. Verfasst von Rebecca M Southern und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell and Developmental Biology, Northwestern University, Chicago, IL, USA. Hauptthemen laut MEDLINE: Immunoglobulin G, Receptors, Antigen, B-Cell, Immunoglobulin M, B-Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIH HHS.
Abstract (Originalsprache)
Malignant B cells rely on B cell receptor (BCR) signals for their survival and growth. Besides the Immunoglobulin M (IgM) BCR, lymphoma cells can also express non–IgM (IgG) BCRs; however, the role of IgG BCRs in malignant B cell is not well understood. Here, we report poorer disease outcomes in diffuse large B cell lymphoma (DLBCL) expressing high IgM versus those expressing IgG1. Using isogenic lymphoma cells expressing distinct BCRs, we found that IgM expressing cells strongly outcompete their IgG1 counterparts. Mechanistically, IgG1 BCR is associated with a dysfunctional mitochondrial state and reduced cell survival. We show that mitochondrial dysfunction is triggered by accentuated calcium responses downstream of IgG1 BCR. Genetic reversal of IgG1 to IgM, pharmacological dampening of calcium signaling, or treatment with interleukin-21 can correct mitochondrial defects and rescue IgG1 survival. Our findings demonstrate that distinct BCR isotypes are inherently unique and can differentially affect B cell lymphoma pathogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell and Developmental Biology, Northwestern University, Chicago, IL, USA.
- Program on Inflammatory Diseases, Infectious and Inflammatory Diseases Center, Sanford Burnham Medical Discovery Institute, La Jolla, CA, USA.
- Department of Pathology, Children's Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Torino, Torino, Italy.
- Division of Hematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy.
- Institute for Molecular Medicine, University Medical Center (UMC), Mainz, Germany.
ORCID-Profile: Rebecca M Southern, Rebecca L Schmitz, Daniela Samaniego-Castruita, Mi Thao Tran, Taek-Chin Cheong, Roberto Chiarle, Ajay Abraham, Ari Waisman, Vipul Shukla, Ashima Shukla
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIH HHS
Zitieren
APA
Southern, R. M., Schmitz, R. L., Samaniego-Castruita, D., Balsells, D., Han, I., Ramesh, P., Tran, M. T., Montes, C., Cheong, T. C., Chiarle, R., Abraham, A., Waisman, A., Rickert, R. C., Shukla, V., & Shukla, A. (2025). IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas. Science Advances, 11(35). https://doi.org/10.1126/sciadv.adp9391
Vancouver
Southern RM, Schmitz RL, Samaniego-Castruita D, Balsells D, Han I, Ramesh P, et al. IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas. Science Advances. 2025;11(35). doi:10.1126/sciadv.adp9391
BibTeX
@article{Southern2025,
author = {Southern, Rebecca M and Schmitz, Rebecca L and Samaniego-Castruita, Daniela and Balsells, Daniel and Han, Isabella and Ramesh, Prathyaya and Tran, Mi Thao and Montes, Carlos and Cheong, Taek-Chin and Chiarle, Roberto and Abraham, Ajay and Waisman, Ari and Rickert, Robert C and Shukla, Vipul and Shukla, Ashima},
title = {IgM and IgG1 B cell receptors differentially affect B cell fates and dictate the pathogenesis of mature B cell lymphomas},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {35},
doi = {10.1126/sciadv.adp9391}
}
EUVIMED